Citation tools
"A Triple-negative Matrix-producing Breast Carcinoma Patient-derived Orthotopic Xenograft (PDOX) Mouse Model Is Sensitive to Bevacizumab and Vinorelbine, Regressed by Eribulin and Resistant to Olaparib." Anticancer Research
40.5
(2020):
2509-2514.
Web. 19 April. 2024.